BIIB vs LGCY · P/E 21, rev $9.89B vs P/E 19, rev $64.2M
Biogen Inc (BIIB) versus Legacy Education Inc. (LGCY) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Legacy Education Inc. (LGCY) is a education & training services company listed on AMEX.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported LGCY revenue for 2025-06-30 was $64.2M. Net income was $7.5M. Revenue was up 39.5% from 2024-06-30 to 2025-06-30. LGCY currently screens at market cap $141.7M and trailing P/E 18.7.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. LGCY currently screens at market cap $141.7M and trailing P/E 18.7.
Not investment advice. Open the BIIB and LGCY stock pages for the full models.
Not investment advice.